CIRM Manufacturing Network Symposium attendees. The California Institute for Regenerative Medicine (CIRM) is driving conversations and collaboration to address the manufacturing challenges of cell and gene therapies (CGT). CIRM hosted its inaugural Manufacturing Network Symposium in South San Francisco, bringing together more than 100 experts and stakeholders from the regenerative medicine field, including scientific leaders … Continue reading Bridging the Gap: CIRM Tackles Cell and Gene Therapy Manufacturing Challenges
Manufacturing
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
A laboratory at UCLA's current good manufacturing practices facility | Photo credit: Elena Zhukova The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $10 million to five facilities as part of the first phase to build a California Cell and Gene Therapy Manufacturing Network. The awards include: Application … Continue reading CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
Apply Now for New Manufacturing Funding Opportunity
The California Institute for Regenerative Medicine (CIRM) has set goals through its five-year strategic plan to continue to deliver the full potential of regenerative medicine to the people of California and around the world. One of those goals is to overcome manufacturing hurdles for the delivery of regenerative medicine therapies by building a public-private manufacturing … Continue reading Apply Now for New Manufacturing Funding Opportunity
If you’re into stem cell manufacturing, this is the conference for you!
Fulfilling CIRM’s mission doesn’t just mean accelerating promising stem cell treatments to patients. It also involves accelerating the whole field of regenerative medicine, which involves not just research, but developing candidate treatments, manufacturing cell therapies, and testing these therapies in clinical trials. Manufacturing and the pre-clinical safety evaluation of cell therapies are topics that don’t … Continue reading If you’re into stem cell manufacturing, this is the conference for you!